loss of heterozygosity
Showing 1 - 25 of >10,000
Collect Samples for TAA, HLA & HLA Loss of Heterozygosity in
Not yet recruiting
- Head and Neck Cancer
- +8 more
- Tumor and HLA Profiling
- (no location specified)
Mar 31, 2023
A Training Set for the HRD Model in EOC
Recruiting
- Epithelial Ovarian Cancer
- +5 more
- Homologous recombination deficiency model
-
Beijing, Beijing, ChinaLei Li
Dec 2, 2020
Esophageal Cancer Treated With Cisplatin, Radiation Therapy, and
Completed
- Esophageal Cancer
- loss of heterozygosity analysis
- +2 more
- (no location specified)
Jul 29, 2020
HR Genes and the HRD Status in Chinese Epithelial Ovarian Cancer
Completed
- Epithelial Ovarian Cancer
- +6 more
- Evaluation of homologous recombination deficiency score
-
Beijing, Beijing, ChinaLei Li
Mar 26, 2022
Sebaceous Cell Tumor of Eyelid Trial in Roma (exome sequencing (retrospective) and exome and methylome sequencing (prospective))
Recruiting
- Sebaceous Cell Tumor of Eyelid
- exome sequencing (retrospective) and exome and methylome sequencing (prospective)
-
Roma, Rome, ItalyGustavo Savino
Oct 8, 2023
Study of Skin Tumors in Tuberous Sclerosis
Recruiting
- Tuberous Sclerosis
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Feb 2, 2023
Product of Conception Derived From Ultrasound-guided Manual
Not yet recruiting
- Product of Conception; Retained, Hemorrhage, Complicating Delivery
- Genetic Anticipation
- Ultrasound-guided manual vaccum
- (no location specified)
Apr 11, 2023
Sarcoma Trial in Rome
Recruiting
- Sarcoma
-
Rome, Italy"Regina Elena" National Cancer Institute
Oct 6, 2023
Solid Tumor, Adult, Colorectal Cancer, NSCLC Trial in United States (A2B694, xT CDx with HLA-LOH Assay)
Not yet recruiting
- Solid Tumor, Adult
- +19 more
- A2B694
- xT CDx with HLA-LOH Assay
-
Duarte, California
- +9 more
Sep 22, 2023
Solid Tumor, Adult, Solid Tumor, Pancreatic Cancer Trial in United States (A2B530, xT-Onco with HLA-LOH Assay)
Not yet recruiting
- Solid Tumor, Adult
- +15 more
- A2B530
- xT-Onco with HLA-LOH Assay
-
Duarte, California
- +6 more
Feb 10, 2023
A Gene Hunting Study for Familial Papillary Thyroid Cancer
Recruiting
- Thyroid
-
Columbus, OhioOhio State University Comprehensive Cancer Center
Oct 13, 2022
Genetics of Endocrine Tumours - Familial Isolated Pituitary
Recruiting
- Acromegaly
- +5 more
-
London, United Kingdom
- +1 more
Oct 17, 2022
Breast Cancer, Triple Negative Breast Tumors Trial in France (Nivolumab, Ipilimumab, Capecitabine)
Active, not recruiting
- Breast Cancer
- Triple Negative Breast Neoplasms
- Nivolumab
- +2 more
-
Angers, France
- +16 more
Jul 21, 2022
Variance of HRD From Paired Ovarian Cancer
Not yet recruiting
- Ovarian Cancer
- +2 more
-
Nanjing, Jiangsu, ChinaXiaoxiang Chen
Sep 25, 2021
Head Neck Cancer, Cervical Cancer, Non-small Cell Carcinoma Trial in Scottsdale, Chapel Hill (TSC-204-A0201, TSC-204-C0702,
Not yet recruiting
- Head and Neck Cancer
- +20 more
- TSC-204-A0201
- +4 more
-
Scottsdale, Arizona
- +1 more
Aug 3, 2023
BRCA1 Gene Mutation, BRCA2 Gene Mutation, Folate Receptor Alpha Positive Trial in Columbus (other, biological, drug)
Active, not recruiting
- BRCA1 Gene Mutation
- +9 more
- Laboratory Biomarker Analysis
- +3 more
-
Columbus, OhioOhio State University Comprehensive Cancer Center
Sep 16, 2022
Therapeutic Targets in Breast Cancer.
Recruiting
- Breast Cancer
-
Napoli, ItalyIstituto Nazionale Tumori - Fondazione "G.Pascale", IRCCS
Apr 4, 2023
Castration Levels of Testosterone, Castration-Resistant Prostate Carcinoma, Metastatic Prostate Carcinoma Trial in Detroit,
Active, not recruiting
- Castration Levels of Testosterone
- +4 more
-
Detroit, Michigan
- +1 more
Aug 30, 2022
CA-IX, p16, Proliferative Markers, and HPV in Diagnosing
Active, not recruiting
- Atypical Endometrial Hyperplasia
- +2 more
- Cytology Specimen Collection Procedure
- Laboratory Biomarker Analysis
-
Tucson, Arizona
- +162 more
Oct 27, 2022
Respiratory Infections Attributable to CFTR Heterozygosity
Not yet recruiting
- Carrier State
- Respiratory Infections
- (no location specified)
Aug 2, 2022
Epithelial Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Carcinoma Trial in United States (Rucaparib, Nivolumab)
Terminated
- Epithelial Ovarian Cancer
- +4 more
-
Clovis, California
- +4 more
May 19, 2021
Study of Kidney Tumors in Younger Patients
Recruiting
- Adult Cystic Nephroma
- +24 more
- Cytology Specimen Collection Procedure
- Laboratory Biomarker Analysis
-
Birmingham, Alabama
- +247 more
Sep 2, 2022
